SGMO 8-K 2026-06-23

SANGAMO THERAPEUTICS, INC (SGMO) 8-K dated 2026-06-23 — accession 0001193125-26-278582. This URL is the filing, not the SGMO hub.

SANGAMO THERAPEUTICS, INC (SGMO) is a biotechnology company listed on NASDAQ.

SANGAMO THERAPEUTICS, INC filed a 8-K on 2026-06-23. Accession 0001193125-26-278582.

Cached items: 1.01, 1.03, 2.03, 2.05. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.

Not investment advice. The SGMO SEC hub lists recent forms. The stock page is the research view.